UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 305

Sortiert nach

Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives

Stem cells translational medicine, 2020-12, Vol.9 (12), p.1549-1557

2020

Volltextzugriff (PDF)

Stem cell transplantation in sickle cell disease: therapeutic potential and challenges faced

Expert review of hematology, 2018-07, Vol.11 (7), p.547-565

2018

Volltextzugriff (PDF)

Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy

Journal of clinical medicine, 2022-08, Vol.11 (16), p.4775

2022

Volltextzugriff (PDF)

CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease

Molecular therapy. Methods & clinical development, 2021-12, Vol.23, p.276-285

2021

Volltextzugriff (PDF)

High-Efficiency Lentiviral Transduction of Human CD34+ Cells in High-Density Culture with Poloxamer and Prostaglandin E2

Molecular therapy. Methods & clinical development, 2019-06, Vol.13, p.187-196

2019

Volltextzugriff (PDF)

In vivo measurement of RBC survival in patients with sickle cell disease before or after hematopoietic stem cell transplantation

Blood advances, 2024-04, Vol.8 (7), p.1806-1816

2024

Volltextzugriff (PDF)

Low-Dose Busulfan Reduces Human CD34+ Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice

Molecular therapy. Methods & clinical development, 2019-12, Vol.15, p.430-437

2019

Volltextzugriff (PDF)

Forced enhancer-promoter rewiring to alter gene expression in animal models

Molecular therapy. Nucleic acids, 2023-03, Vol.31, p.452-465

2023

Volltextzugriff (PDF)

Correction to: Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation

Stem cell research & therapy, 2020-12, Vol.11 (1), p.544-544, Article 544

2020

Volltextzugriff (PDF)

Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?

British journal of haematology, 2020-05, Vol.189 (3), p.408-423

2020

Volltextzugriff (PDF)

Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospital

Frontiers in medicine, 2023-02, Vol.10, p.987194-987194

2023

Volltextzugriff (PDF)

Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models

Cell reports. Medicine, 2021-04, Vol.2 (4), p.100247, Article 100247

2021

Volltextzugriff (PDF)

A pause in gene therapy: Reflecting on the unique challenges of sickle cell disease

Molecular therapy, 2021-04, Vol.29 (4), p.1355-1356

2021

Volltextzugriff (PDF)

A new frontier: FDA approvals for gene therapy in sickle cell disease

Molecular therapy, 2024-02, Vol.32 (2), p.264-267

2024

Volltextzugriff (PDF)

Current and emerging drug treatment strategies to tackle sickle cell anemia

Expert opinion on emerging drugs, 2024-07, p.1-20

2024

Volltextzugriff (PDF)

Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies

Human molecular genetics, 2020-09, Vol.29 (R1), p.R100-R106

2020

Volltextzugriff (PDF)

Gene Therapy for Hemoglobinopathies

Hematology/oncology clinics of North America, 2022-08, Vol.36 (4), p.769-795

2022

Volltextzugriff (PDF)

Hematopoietic stem cell collection for sickle cell disease gene therapy

Current opinion in hematology, 2024-05, Vol.31 (3), p.104

2024

Volltextzugriff (PDF)

Gene therapy for sickle cell disease

Hematology, 2023-12, Vol.2023 (1), p.542

2023

Volltextzugriff (PDF)

Gene Therapy for Hemoglobinopathies: Beta-Thalassemia, Sickle Cell Disease

Hematology/oncology clinics of North America, 2022-08, Vol.36 (4), p.769-795

2022

Volltextzugriff (PDF)

Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease

Expert review of hematology, 2023-11, Vol.16 (11), p.879-903

2023

Volltextzugriff (PDF)

Intranasal administration of acetylcholinesterase inhibitors

BMC neuroscience, 2008-12, Vol.9 Suppl 3 (S3), p.S6-S6, Article S6

2008

Volltextzugriff (PDF)

Pulmonary Function before and after Hematopoietic Cell Transplant in People Living with Sickle Cell Disease

Blood, 2022-11, Vol.140 (Supplement 1), p.8294-8295

2022

Volltextzugriff (PDF)

Efficacy and safety of long-term sirolimus use as part of multidisciplinary care in a pediatric patient with CLOVES syndrome: Case report

Translational science of rare diseases, 2022-04, Vol.6 (1-2), p.25-32

2022

Volltextzugriff (PDF)

Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation

Cytotherapy (Oxford, England), 2022-03, Vol.24 (3), p.249-261

2022

Volltextzugriff (PDF)

1 – 25 von 305

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(274)
Mit Volltextzugriff
(271)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives

Stem cell transplantation in sickle cell disease: therapeutic potential and challenges faced

Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy

CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease

High-Efficiency Lentiviral Transduction of Human CD34+ Cells in High-Density Culture with Poloxamer and Prostaglandin E2

In vivo measurement of RBC survival in patients with sickle cell disease before or after hematopoietic stem cell transplantation

Low-Dose Busulfan Reduces Human CD34+ Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice

Forced enhancer-promoter rewiring to alter gene expression in animal models

Correction to: Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation

Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?

Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospital

Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models

A pause in gene therapy: Reflecting on the unique challenges of sickle cell disease

A new frontier: FDA approvals for gene therapy in sickle cell disease

Current and emerging drug treatment strategies to tackle sickle cell anemia

Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies

Gene Therapy for Hemoglobinopathies

Hematopoietic stem cell collection for sickle cell disease gene therapy

Gene therapy for sickle cell disease

Gene Therapy for Hemoglobinopathies: Beta-Thalassemia, Sickle Cell Disease

Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease

Intranasal administration of acetylcholinesterase inhibitors

Pulmonary Function before and after Hematopoietic Cell Transplant in People Living with Sickle Cell Disease

Efficacy and safety of long-term sirolimus use as part of multidisciplinary care in a pediatric patient with CLOVES syndrome: Case report

Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation

Suchergebnisse filtern